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Summary Sentence: Peritoneal macrophages exhibit sexually dimorphic transcriptional profiles, 1 
functional capacity and replenishment kinetics.  2 
  3 
 
Abstract 1 
 2 
Macrophages reside in the body cavities where they maintain serosal homeostasis and provide immune 3 
surveillance. Peritoneal macrophages are implicated in the etiology of pathologies including peritonitis, 4 
endometriosis and metastatic cancer thus understanding the factors that govern their behavior is vital. Using 5 
a combination of fate mapping techniques, we have investigated the impact of sex and age on murine 6 
peritoneal macrophage differentiation, turnover and function. We demonstrate that the sexually dimorphic 7 
replenishment of peritoneal macrophages from the bone marrow, which is high in males and very low in 8 
females, is driven by changes in the local microenvironment that arise upon sexual maturation. Population 9 
and single cell RNAseq revealed striking dimorphisms in gene expression between male and female 10 
peritoneal macrophages that was in part explained by differences in composition of these populations. By 11 
estimating the time of residency of different subsets within the cavity and assessing development of 12 
dimorphisms with age and in monocytopenic Ccr2–/– mice, we demonstrate that key sex-dependent features 13 
of peritoneal macrophages are a function of the differential rate of replenishment from the bone marrow 14 
while others are reliant on local microenvironment signals. Importantly, we demonstrate that the dimorphic 15 
turnover of peritoneal macrophages contributes to differences in the ability to protect against pneumococcal 16 
peritonitis between the sexes. These data highlight the importance of considering both sex and age in 17 
susceptibility to inflammatory and infectious diseases.  18 
 19 
 20 
  21 
 
Introduction 1 
 2 
Macrophages are present in every tissue of the body, where they provide immune protection and 3 
orchestrate tissue repair following insult or injury. Peritoneal macrophages are arguably the most 4 
studied population of macrophages in the body, having been used extensively as a convenient 5 
source of macrophages for ex vivo analyses for decades. In spite of this body of knowledge, the 6 
heterogeneity of peritoneal macrophages and much of the biology that governs their development, 7 
differentiation, and function remains unclear. Macrophages in the peritoneal cavity are 8 
programmed for ‘silent’ clearance of apoptotic cells, maintenance of innate B1 cells through 9 
secretion of CXCL13, and for immune surveillance of the cavity and neighboring viscera (1-4). 10 
However, they are also implicated in many pathologies, including peritonitis, endometriosis, post-11 
surgical adhesions, pancreatitis and metastatic cancer (5-15), although the exact roles they play in 12 
these processes are not fully understood.  13 
Under physiological conditions, at least two macrophage populations are present in the 14 
murine peritoneal cavity, with those expressing high levels of F4/80, CD11b and CD102 15 
outnumbering their F4/80loMHCII+ counterparts by approximately 10-fold. F4/80hiCD102+ 16 
macrophages (sometimes referred to as ‘large’ peritoneal macrophages (16)) rely on the 17 
transcription factors C/EBPb and GATA6 for their differentiation and survival (17-20), with the 18 
latter under the control of retinoic acid proposed to derive, in part, from the omentum (19). The 19 
F4/80loMHCII+ compartment is heterogeneous, comprising both macrophages and conventional 20 
dendritic cells (21-24). F4/80loMHCII+ macrophages  (sometimes referred to as ‘small’ peritoneal 21 
macrophages or monocyte-derived DC) rely on IRF4 for their differentiation and can be further 22 
defined by their expression of CD226 and the immunomodulatory molecule RELMa (21, 23, 24). 23 
Notably, recent studies employing lineage tracing techniques have established that F4/80loMHCII+ 24 
 
macrophages arise postnatally, are short-lived and replaced by Ly6Chi classical monocytes in a 1 
CCR2-dependent manner (20-23). In contrast, F4/80hiCD102+ macrophages are longer-lived cells 2 
that derive from embryonic sources, but are subsequently replaced by cells of hematopoietic stem 3 
cell (HSC) origin (21, 25). Importantly, we have recently shown that unlike resident macrophages 4 
in numerous other tissues the turnover of peritoneal F4/80hiCD102+ macrophages from the bone 5 
marrow is highly sex-dependent, with high and low rates in male and female mice, respectively 6 
(21). We have also shown that long-lived macrophages can be identified by their expression of the 7 
phagocytic receptor, Tim4, whereas most recent descendants of BM-derived cells amongst the 8 
F4/80hiCD102+ macrophage compartment are Tim4–(21). Indeed Tim4 expression has been shown 9 
to a feature of long-lived macrophages in other tissues (26-30). However, it remains unclear if 10 
further heterogeneity exists amongst these broadly-defined populations and if sexually-dimorphic 11 
turnover influences the composition and function of the F4/80hiCD102+ macrophage population in 12 
other ways.  13 
Sex is a variable often overlooked in immunological research (31) despite strong sex biases 14 
in many pathologies including autoimmune disorders and infection susceptibility (32). Notably, 15 
sex dimorphisms in the immune system are present a diverse range of species from insects, bird, 16 
lizards, and mammals (32), suggesting that this may be an evolutionarily conserved phenomenon. 17 
It is therefore essential to understand how intrinsic factors, such as sex, control the behavior of 18 
innate immune effector cells. Specifically, sex has been proposed to affect macrophage behavior, 19 
such as influencing the differentiation of brain microglia, (33-35) and sex hormones appear able 20 
to directly regulate gene expression (36) and proliferation (37) of macrophages. Whereas previous 21 
studies have considered the effects of sex on peritoneal macrophage behavior, many of these have 22 
focused on in vitro functional assessments using macrophages elicited by injection of an irritant or 23 
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inflammatory agent (38), or they have not appreciated the complexity of the peritoneal macrophage 1 
compartment (37, 39). 2 
Here, we have used a combination of fate-mapping techniques together with population-3 
level and single cell RNA sequencing (scRNAseq) to dissect the role of sex in the composition, 4 
environmental imprinting, and function of peritoneal macrophages. We show that the 5 
F4/80hiCD102+ macrophage population is heterogeneous, and that dimorphic turnover is 6 
associated with divergence in the heterogeneity of this compartment with age. Specifically, we 7 
demonstrate that the sexual dimorphism in replenishment from the bone marrow and phenotype 8 
arise following sexual maturation. Furthermore, we provide examples of transcriptional and 9 
functional dimorphisms that arise due to sex differences in turnover versus those arising directly 10 
from sex differences in the peritoneal microenvironment. Importantly, we identify the C-type 11 
lectin receptor CD209b (also known as Specific ICAM3-grabbing nonintegrin-related 1; SIGN-12 
R1) as a marker whose expression is determined by replenishment that becomes increasingly 13 
dimorphic with age, and show that sex-dependent resistance to pneumococcal peritonitis arises, in 14 
part, due to dimorphic expression of CD209b.   15 
 16 
Results 17 
Environmental factors drive sexual dimorphism in peritoneal macrophage replenishment 18 
We first set out to determine if the dimorphic effects in peritoneal macrophage replenishment were due to 19 
the peritoneal environment or to cell-intrinsic differences in the ability of male and female monocytes to 20 
generate F4/80hiCD102+ macrophages at this site. To this end, we generated sex-mismatched, tissue-21 
protected bone marrow (BM) chimeric mice to measure the turnover of peritoneal F4/80hiCD102+ 22 
macrophages from the BM (Fig. 1A & Fig. S1A) and assess the role of sex in this process. Wild type 23 
(CD45.1/.2+) mice were irradiated, with all but the head and upper torso protected with lead to prevent 24 
 	
direct exposure to ionising radiation (Fig. 1B), before being reconstituted with sex-matched (female > 1 
female, male > male) or sex-mismatched (female > male, male > female) BM. Following at least 8 weeks 2 
reconstitution, the non-host chimerism was measured in peritoneal macrophages. Consistent with our 3 
previous work (21), only low levels of non-host chimerism could be detected amongst peritoneal 4 
F4/80hiCD102+ macrophages from female > female BM chimeric mice, whereas high levels were detected 5 
in their male > male counterparts (Fig. 1C&D, & Fig. S1B), confirming marked sex dimorphism in 6 
macrophage turnover. Importantly, this dimorphism was specific to F4/80hiCD102+ peritoneal 7 
macrophages, as all other leukocyte subsets showed identical replenishment in male and female BM 8 
chimeric mice (Fig. S1C). Strikingly, F4/80hiCD102+ peritoneal macrophages from sex mismatched 9 
(female > male) chimeras had similar levels of chimerism to male > male chimeras (Fig. 1C&D), 10 
demonstrating that female and male monocytes have equal ability to generate F4/80hiCD102+ macrophages 11 
in the male peritoneal cavity. Female recipients rejected male BM and thus chimerism in this group could 12 
not be determined. 13 
 The omentum has been implicated in the differentiation of F4/80hi macrophages in the peritoneal 14 
cavity, potentially acting as site of macrophage maturation (19, 40, 41). Indeed, CD102+ macrophages that 15 
co-express GATA6, can be detected amongst omental isolates (19), together with CD102–MHCII+ 16 
macrophages and a population of Ly6C+ CD11b+ cells similar to monocytes (Fig. 1E and Fig. S1D,E). To 17 
determine if the dimorphic replenishment of peritoneal F4/80hiCD102+ macrophages arises in the omentum, 18 
we assessed non-host chimerism in the macrophage populations within this site. While this showed clear 19 
differences in the turnover of CD102-defined macrophage populations from BM, with higher replenishment 20 
in the CD102– fraction, no sex dimorphism was detected in any monocyte/macrophage population within 21 
the omentum (Fig. 1F). Furthermore, the chimerism of omental and peritoneal CD102+ macrophages in 22 
male recipients was identical, rather than showing the gradation that would have been expected if omental 23 
macrophages were intermediate precursors between monocytes and cavity CD102+ cells (Fig. S1F). Thus, 24 
the sexual dimorphism in peritoneal F4/80hiCD102+ macrophage replenishment is driven by factors present 25 
in the local environment.  26 
 

 1 
Sexual dimorphism in peritoneal macrophage replenishment occurs following sexual maturity 2 
To extend these findings and to assess macrophage turnover at different stages of maturity, we next used a 3 
genetic fate mapping approach. Adoptive transfer experiments suggest F4/80loMHCII+ macrophages in the 4 
peritoneal macrophage compartment act, in part, as precursors of F4/80hiCD102+ macrophages (20) and we 5 
have recently shown that this differentiation can be mapped by exploiting their expression of CD11c (21). 6 
Thus, in CD11cCre.Rosa26LSL-eYFP mice (Fig. 2A), in whom active or historic expression of CD11c leads to 7 
irreversible labelling with eYFP, labelled cells accumulate with age in the F4/80hiCD102+ macrophage 8 
compartment, despite these cells themselves not actively expressing CD11c (21). We therefore used 9 
CD11cCre.Rosa26LSL-eYFP mice to compare the rate of eYFP+ cell accumulation in peritoneal F4/80hiCD102+ 10 
macrophages from male and female mice. In juvenile/prepubescent mice (4 weeks of age), the extent of 11 
eYFP labelling was relatively similar between male and female peritoneal F4/80hiCD102+ macrophages and 12 
indeed was marginally higher in female mice (Fig. 2B & Fig. S2A). By 16 weeks of age, the frequency of 13 
eYFP+ cells amongst F4/80hiCD102+ macrophages had increased in both male and female mice compared 14 
with their 4-week-old counterparts. However, although there was no difference in CD11c protein expression 15 
by male and female F4/80hiCD102+ macrophages (Fig. 2C), higher levels of eYFP labelling were detected 16 
amongst male peritoneal macrophages, consistent with more rapid accumulation of newly differentiated 17 
macrophages in male mice (Fig. 2B). Consistent with our previous findings made using tissue-protected 18 
BM chimeras (21), the sexual dimorphism in eYFP labelling was not detected in F4/80hiCD102+ 19 
macrophages from the pleural cavity (Fig. 2D), where both male and female pleural cells exhibited high 20 
levels of labelling that were equivalent to those seen in the male peritoneal cavity by 16 weeks. Collectively, 21 
these data confirm that the peritoneal environment controls macrophage turnover and suggest that 22 
dimorphisms arise in this site following sexual maturity. 23 
 24 
Ovariectomy leads to increased macrophage replenishment 25 
 
The onset of sexually dimorphic turnover of peritoneal macrophages following sexual maturation and the 1 
uniquely slow replenishment of female peritoneal macrophages suggested that factors involved in female 2 
reproductive function may drive this dimorphism. Therefore, we next assessed macrophage turnover in 3 
females after ovariectomy (OVX). Thus, female > female tissue protected BM chimeric were generated and 4 
after 8 weeks reconstitution, both ovaries were surgically removed (bilateral OVX), before measuring non-5 
host chimerism after another 8 weeks. To account for the potential effects of surgery on macrophage 6 
replenishment, BM chimeric mice receiving sham surgery or unilateral OVX were used as controls, together 7 
with unmanipulated BM chimeric mice. As expected, the cessation of ovarian estradiol production caused 8 
by bilateral OVX led to complete atrophy of the uterine horn; this was not seen in mice with unilateral 9 
OVX, or in other control groups (Fig. 3A). Bilateral OVX had no effect on the numbers of F4/80hiCD102+ 10 
and CD102–MHCII+ macrophages in the peritoneal cavity when compared with the control groups (Fig. 11 
3B). Although bilateral OVX led to increased proportions and absolute numbers of eosinophils, these 12 
differences did not attain statistical significance and the opposite pattern was found with B1 cells (Fig. 13 
S2B-I). Importantly and in striking contrast to the very low levels of chimerism (~1%) detected in 14 
unmanipulated control chimeras (Fig. 3C), sham surgery and unilateral OVX led to significant increases 15 
the level of chimerism compared with unmanipulated chimeric mice, demonstrating that minimally-16 
invasive laparotomy itself appears to have long term effects on the dynamics of peritoneal macrophages in 17 
female mice. Nevertheless, complete removal of the ovaries further elevated macrophage turnover, with 18 
chimerism reaching approximately 12%. No difference was found between the chimerism seen after sham 19 
surgery with or without unilateral OVX, indicating that the OVX procedure itself does not exaggerate the 20 
effects of laparotomy and that it is the compete loss of ovarian function that underlies the further elevation 21 
in macrophage turnover that results from bilateral OVX. Consistent with these results, significantly more 22 
Tim4–CD102+ macrophages were present in the cavity of mice that received bilateral OVX than any other 23 
group (Fig. 3D), further supporting the idea of elevated macrophage replenishment from BM. Notably, no 24 
differences in chimerism or in Tim4-defined subsets could be detected amongst F4/80hiCD102+ 25 
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macrophages from the pleural cavity, again confirming that the effect of surgery and ovariectomy on 1 
macrophage turnover are specific to the peritoneal cavity (Fig. 3B, C).  2 
Estrogens are the prototypical female sex steroid hormones, which are ablated by OVX. To assess 3 
if estrogen influences macrophage replacement, we repeated the OVX experiment with an additional group 4 
of bilateral OVX mice receiving exogenous estradiol (E2). However, while this treatment reversed OVX-5 
mediated atrophy of the uterine horns and peritoneal eosinophilia, it had no effect on the heightened rate of 6 
replenishment of F4/80hiCD102+ peritoneal macrophages in OVX mice, suggesting that estradiol is not 7 
directly responsible for generating the sex dimorphism in peritoneal macrophage turnover (Fig. 3E). As 8 
males exhibit much greater levels of adipose tissue in the peritoneal cavity (Fig. S3), and a common feature 9 
of ovariectomy/oophorectomy in mice and humans is increased adiposity (42, 43), we combined a high fat 10 
diet (HFD) with our BM chimeric system to reveal if changes in adiposity affect replenishment of peritoneal 11 
F4/80hiCD102+ macrophage. However, replenishment was not affected by diet in either males or females, 12 
despite the expected increase in body weight and adipose tissue seen in mice on an HFD (Fig. S3). Hence, 13 
sexual maturation controls dimorphic turnover in the peritoneal cavity through a mechanism controlled at 14 
least in part by the female reproductive system, but independently of estrogen and local fat deposition. 15 
 16 
 17 
Sex determines the transcriptional signature of peritoneal macrophages 18 
The difference in macrophage replenishment prompted us to assess the wider effects of sex on the 19 
imprinting of peritoneal macrophage identity and function. We therefore first performed population-level 20 
RNASeq on peritoneal F4/80hiCD102+ macrophages FACS-purified from unmanipulated 10-12 week old 21 
male and female mice (Fig. S4). To limit potential confounding effects of the estrous cycle, the stage of 22 
each female mouse was confirmed by vaginal cytology and samples pooled to include cells from all stages 23 
of the cycle. Furthermore, to limit the effects of circadian influence, mice in each biological replicate were 24 
euthanised at the same time each day. Unbiased clustering was then used to group the populations based on 25 
sex, with sex explaining 81% of the variance within the datasets (Fig. 4A) and differential gene expression 26 
 
analysis revealed that 486 mRNA transcripts were differentially expressed (>1.5fold) between female and 1 
male peritoneal CD102+ macrophages (Fig. 4B & Table S1). Analysis of the 148 mRNA transcripts more 2 
highly expressed in female peritoneal macrophages revealed that a large proportion was associated with 3 
immune function, including the C-type lectin receptors Clec4g, Cd209a and Cd209b, the complement 4 
components C4b, C1qa, and C3 the immunoregulatory cytokine Tgfb2, the B cell chemoattractant Cxcl13, 5 
and as expected the phagocytic receptor Timd4 (Fig. 4C & Table S1). Consistent with this, ‘immune 6 
response’ and ‘immune system processes’ were among the top pathways identified by gene-set enrichment 7 
analysis in genes up-regulated in female cells (Table S2). Transcripts for the apolipoproteins Apoe, Saa2, 8 
Saa3 and Apoc1 were also expressed more highly in female cells. Notably, in contrast to previous work that 9 
assessed basal gene expression by total peritoneal cells across the sexes (39), we did not detect any 10 
dimorphism in expression of toll-like receptors (TLRs), the TLR adaptor molecule MyD88 or CD14 (Fig. 11 
S5). Moreover, the dimorphic cassette of genes we identified is distinct from that recently shown to be 12 
sexually dimorphic in microglia (Fig. S5A, B), consistent with previous reports that transcriptional 13 
differences between sexes in macrophages are largely tissue-specific (44).  14 
We used flow cytometry to confirm higher expression of Cd209b, Cxcl13, and Apoc1 by female 15 
macrophages, as these were the most differentially expressed non-X-linked genes with mapped read counts 16 
greater than 10. This analysis revealed unexpected heterogeneity within resident peritoneal macrophages. 17 
For instance, only a proportion of male and female CD102+ macrophages expressed CD209b, although the 18 
frequency of these was greater in females than in males (35% and 20% respectively). Moreover, CD209b 19 
was expressed at a higher level on a per cell basis by female CD102+ macrophages compared with their 20 
male counterparts (Fig. 4C), a finding consistent across different strains, including Rag1–/– mice, and mice 21 
from different housing environments (Fig. S6). Due to the unavailability of commercial antibodies for 22 
CXCL13, ApoE and ApoC1, we used PrimeFlow technology to measure mRNA of these genes at a single 23 
cell level using flow cytometry (Fig. S5C). Again, this revealed that a greater proportion of female CD102+ 24 
macrophages expressed mRNA for CXCL13 and ApoC1 than their male counterparts, and CXCL13 mRNA 25 
was also higher on a per cell basis in female cells (Fig. 4D, E). In contrast, PrimeFlow measurement of 26 
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mRNA for ApoE, the most highly expressed of all differentially expressed genes by female cells by 1 
RNAseq, revealed that all peritoneal macrophages expressed ApoE irrespective of sex, but that expression 2 
was higher in female cells on a per cell basis. Hence, the transcriptional differences seen at population level 3 
appear to result from differential gene expression at a single cell level but also from different frequencies 4 
of gene-expressing cells amongst the CD102+ population. 5 
The majority of genes more highly expressed by male peritoneal CD102+ macrophages were 6 
associated with cell cycle, including Cdk1, E2f2, and Mki67 (Fig. 4B & Table S1). Pathway analysis also 7 
revealed that at least 162 of the 338 genes differentially up-regulated in male CD102+ macrophages were 8 
associated with proliferation, and cell cycle-related processes predominated among the significantly 9 
enriched pathways (Table S2). Short-term BrdU pulse-chase experiments confirmed that male CD102+ 10 
macrophages have elevated levels of in situ proliferation compared with their female counterparts (Fig. 11 
4G). These analyses also identified that Retlna, which encodes the immunomodulatory cytokine RELMa 12 
and is expressed specifically by those resident peritoneal macrophages that are most recently-derived from 13 
monocytes (21), was differentially expressed between sexes, with higher expression by male cells at both 14 
the mRNA and protein level (Fig. 4H).  15 
Of note, a number of genes previously reported to distinguish long-lived, embryonically-derived 16 
macrophages from those of recent BM origin in the lung and liver were more highly expressed in females. 17 
These included receptors involved in phagocytosis and immunity (i.e. Timd4, Colec12, and Cd209 family 18 
members), Apoc1, as well as the bone morphogenic receptor Bmpr1a (Table S1) (26, 45, 46). Lowering 19 
the stringency of selection of differentially-expressed genes identified additional genes within the female-20 
specific cluster that have been associated with embryonically-derived or long-lived macrophages, including 21 
Cd163 that also encodes a phagocytic receptor (26) (46). Furthermore, to discern systemic from local effects 22 
of sex, we compared gene expression by CD102+ macrophages from female peritoneal cavity to pleural 23 
CD102+ macrophages from both sexes. This analysis identified a module of 18 genes that was uniquely 24 
upregulated by female peritoneal macrophages, and that included Apoc1, Cd209b, and Colec12, as well as 25 
Saa3, C4b, and Tgfb2 (Table S3). Conversely, the 86 genes uniquely downregulated by female peritoneal 26 
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macrophages compared with the other CD102+ populations were highly enriched for cell cycle related genes 1 
and pathways (Table S3&4). Thus, the more limited proliferative activity of female peritoneal macrophages 2 
and their expression of numerous immune-related genes appear either related to their slower replenishment 3 
from the bone-marrow or regulated directly by the unique signals present within the female peritoneal 4 
microenvironment. 5 
 6 
scRNA-seq reveals equivalent cluster identities in male and female peritoneal macrophages but these 7 
exhibit dimorphisms in abundance and gene expression 8 
We next applied single cell RNA sequencing (scRNA-seq) to determine whether the transcriptional 9 
differences seen in our population-level data were the result of gene differences at a single cell level or if 10 
dimorphism was a reflection of differential subset composition between the sexes. A broad approach was 11 
used to capture all CD11b+ cells depleted of granulocytes and B1 B cells to allow both CD102–12 
F4/80loMHCII+ mononuclear phagocytes and resident CD102+ cells to be examined. These cells were 13 
FACS-purified from age-matched 12-week-old male and female mice and droplet-based scRNASeq 14 
performed using the 10X Genomics platform. 10,000 sorted cells of each sex were sequenced and following 15 
quality control, analysis was performed on 4341 and 2564 cells from female and male respectively.  16 
Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction analysis 17 
revealed 6 clusters that were present in both male and female cells (Fig. 5A,B). Given that the starting 18 
population of CD11b+ cells is known to be phenotypically heterogeneous, containing resident 19 
CD102+F4/80hi macrophages, CD102–F4/80lo MHCII+ macrophages and CD11c+MHCII+ cDC2 (20-23), 20 
we first used a panel of known markers to validate subset identity (Fig. 5B). 3 clusters of resident 21 
macrophages (3-5) could be identified on the basis of their high expression of Adgre1 (F4/80) and Icam2 22 
(CD102). As expected, these were clearly distinct from short-lived CD102–F4/80loMHCII+ macrophages 23 
and cDC2, which were found in clusters 1 and 2 respectively, and expressed Ccr2 (Fig. 5C, D) (21). 24 
However, CD102–F4/80loMHCII+ macrophages and cDC2 could be distinguished from one another on the 25 
basis of expression of the DC markers Cd209a and Napsa (28, 47), and of Retnla and Fclrs, which we and 26 
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others have shown to be signature markers of cavity CD102–F4/80loMHCII+ macrophages (21, 23, 48). 1 
Cluster 6 was defined by genes associated with cell cycle, such as Mki67 and Birc5, suggesting this cluster 2 
represents proliferating cells. In both sexes, the majority of cells was in cluster 5 (Fig. 5E), which was 3 
characterised by markers of resident F4/80hiCD102+ macrophages including Icam2, Prg4, VSig4 and Tgfb2 4 
(Fig, 5C, D & Table S5) that form part of the core peritoneal macrophage-specific transcriptional signature 5 
(49); cluster 5 cells also expressed markers of long-lived macrophages, including Timd4 and Apoc1, 6 
confirming the findings above. Although the cells in cluster 3 expressed Icam2, they also expressed a 7 
number of genes that were highly expressed by the CD102–F4/80loMHCII+ macrophages in cluster 2, such 8 
as Retnla, H2.Aa and Ccr2, suggesting a common origin of these clusters, or a close relationship between 9 
them. This analysis also identified genes expressed more highly by cluster 3, including Folr2, which 10 
encodes the beta subunit of the folate receptor (FRb). Although cluster 4 showed a distinct pattern of gene 11 
expression, such as high expression of Apoe, it also shared features with cluster 3 and cluster 5, suggesting 12 
it may contain differentiation intermediates. Consistent with our earlier analysis, we found that the Timd4-13 
expressing cluster 5 was more abundant amongst female cells, whereas more male cells were found within 14 
clusters 1, 2, 3 and 6 (Fig. 5C).  15 
 We next used flow cytometry to validate the additional heterogeneity uncovered by our scRNA-16 
seq analysis. Consistent with the unbiased clustering and our previous study (21), macrophages expressing 17 
Tim4 (corresponding to cluster 5) were more abundant in female than in male mice (Fig. 5F, G). Moreover, 18 
using this strategy we validated high expression of ApoC1, V-set immunoglobulin-domain-containing 4 19 
(VSIG4) and CXCL13 by this subset of cells (Fig. 5H and Fig. S7A). Although not identified as a cluster 20 
defining gene in our scRNAseq analysis due to low coverage, we found that CD209b displayed the same 21 
pattern of expression as CXCL13 (Fig. 5H). Again, confirming our scRNA-seq, we found the Tim4– 22 
fraction of CD102+ macrophages to be more abundant in males. Macrophages lacking Tim4 expression 23 
could be divided into MHCII+ and MHCII– subsets, which corresponded to clusters 3 and 4 in our scRNA-24 
seq analysis (Fig. 5F,G). Consistent with this, we found that FRb was highly and selectively expressed at 25 
 
protein level by Tim4–MHCII+ CD102+ macrophages (Fig. 5I), and these expressed RELMa at a higher 1 
level than all other CD102+ macrophages (Fig. 5J). While Apoe was proposed to define cluster 4 in our 2 
scRNAseq analysis, we found it was expressed by all CD102+ macrophages (Fig. 4F), although, in females, 3 
it was most highly expressed by Tim4–MHCII+ and the level decreased progressively to Tim4+MHCII– 4 
CD102+ macrophages (Fig. 5K). The phenotypic profile of cluster 3 (MHCII+Tim4–CD102+) suggested 5 
that they may represent the most derivatives from CD102–F4/80loMHCII+ macrophages. Consistent with 6 
this, they also expressed the highest level of CX3CR1, which is highly expressed by CD102–F4/80loMHCII+ 7 
macrophages (Fig. 5L). To test this directly, we reanalysed our data from adult CD11cCre.Rosa26LSL-eYFP 8 
mice to assess if MHCII/Tim4-defined subsets showed differential levels of replenishment. Notably, we 9 
found that MHCII-expressing Tim4–CD102+ macrophages showed equivalent labelling to CD102–10 
F4/80loMHCII+ macrophages in female CD11cCre.Rosa26LSL-eYFP mice, indicative of more recent derivation 11 
from CD102–F4/80loMHCII+ cells (Fig. 5M). Consistent with their intermediate transcriptional profile, 12 
Tim4–CD102+ macrophages that had lost MHCII expression showed intermediate labelling when compared 13 
with their MHCII+Tim4– and Tim4+ counterparts. No difference in eYFP labelling between Tim4-defined 14 
subsets was noted in male mice, consistent with more rapid replenishment of all subsets of macrophages in 15 
this environment. Collectively these data show that excluding proliferating cells, resident peritoneal 16 
macrophages comprise three main clusters, with Tim4– macrophages displaying an intermediate phenotype 17 
compared with F4/80loMHCII+ macrophages and Tim4+ macrophages. Furthermore, while equivalent 18 
clusters of CD102+ peritoneal macrophages are found in males and females, our analysis suggests that 19 
sexual dimorphisms in gene expression in CD102+ cells identified by population level RNA-seq arise in 20 
part due to differences in abundance of these clusters. 21 
Finally, we performed differential gene expression analysis on our scRNA-seq datasets to 22 
distinguish dimorphisms that arise due to differential gene expression across all CD102+ cells irrespective 23 
of cluster identity from those that only occur within individual clusters, and potentially reveal sex-24 
dependent gene expression not detected by our population-level RNAseq analysis. Excluding X and Y-link 25 
genes and mitochondrial or ribosomal related genes that can arise from stress induced during cell isolation, 26 
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this identified 51 and 116 genes expressed more highly by female and male cells, respectively (Table S6). 1 
Almost 50% of these gene differences were validated by our population level RNA-seq dataset when the 2 
1.5 log-fold cut-off limit was removed to allow detection of subtle differences (Table S6). For instance, in 3 
keeping with our PrimeFlow analysis (Fig. 5H, 5K & Table S7), Cxcl13 and Apoe were found to be more 4 
highly expressed in female cells of all clusters of CD102+ macrophages (Table S6). Similarly, Saa3, C4b 5 
and Timp2 were found to be more highly expressed by female CD102+ macrophages irrespective of cluster 6 
identity, whereas Vim, Arg1, S100 family genes and SerpinB2 and Serpbin B1a were among those genes 7 
expressed more highly by male CD102+ cells irrespective of cluster. However, over 50% of differentially 8 
expressed genes were either unique to a single cluster of CD102+ macrophages or shared across only 2 of 9 
the 3 populations (Table S6). For example, in spite of being a defining marker of cluster 5, Timd4 was also 10 
identified as being differentially expressed within this cluster between the sexes. Consistent with this, 11 
female Tim4+ macrophages expressed markedly more surface Tim4 on per-cell basis (Fig. 5N). 12 
Furthermore, Folr2 and Vsig4, neither of which had been identified by population-level RNAseq analysis, 13 
were both identified by scRNA-seq (Table S6) and flow cytometry (Fig.5I & Table S7) to be expressed 14 
more highly by female cells within cluster 4 (MHCII– Tim4–). However, there were some discrepancies 15 
between datasets. For example, while Cd209b expression appeared uniquely dimorphic within cluster 5 16 
(Table S6), our flow cytometric analysis suggested that all clusters of CD102+ macrophages exhibit a 17 
degree of differential expression of this receptor (Fig. 5H and Table S7). Furthermore, while Apoc1 was 18 
identified as differentially expressed across all clusters of female cells (Table S6), our Primeflow analysis 19 
suggests this dimorphism is restricted to cluster 5 (Fig. 5H and Table S7). Such discrepancies likely reflect 20 
detection biases between these methods and highlight the need for validation of differentially expressed 21 
genes. Nevertheless, our scRNA-seq analysis revealed that pan-cluster and cluster-specific dimorphisms in 22 
gene expression contribute to the distinct transcriptional landscape of male and female peritoneal 23 
macrophages.   24 
 25 
 26 
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Differential replenishment and environmental signals drive the dimorphic features of peritoneal 1 
macrophages 2 
To dissect the dimorphic features of CD102+ macrophages that could be related to longevity from those 3 
more directly controlled by dimorphic environmental signals, we next assessed expression of these in Ccr2–4 
/– mice in whom macrophage replenishment is markedly reduced due to severe monocytopenia (50, 51). 5 
Strikingly, the frequency of Tim4– macrophages, as well as those expressing RELMa, FRb or MHCII were 6 
markedly reduced in Ccr2–/– mice compared with Ccr2+/+ mice irrespective of sex, confirming these cells 7 
to be recently derived from monocytes (Fig. 6A). In males, CCR2 deficiency also led to reduced expression 8 
of ApoE and emergence of an ApoE– subset of CD102+ macrophages (Fig. 6B). In contrast, a higher 9 
proportion of CD102+ macrophages in Ccr2–/–- mice expressed CD209b and ApoC1, markers that are 10 
characteristic of the Tim4+MHCII– subset, suggesting these markers may be expressed selectively by long-11 
lived macrophages (Fig. 6B). Consistent with this, Tim4+ macrophages expressing CD209b displayed the 12 
lowest level of replacement by donor cells in BM chimeras when compared with all other CD209b/Tim4-13 
defined macrophages, even in male mice where overall replenishment from the bone marrow is markedly 14 
higher (Fig. 6C). The low levels of replacement of peritoneal CD209b+Tim4+ macrophages does not reflect 15 
derivation from yolk sac progenitors, as, unlike microglia in the brain, these cells are not labelled in male 16 
or female Cdh5Cre-ERT2.Rosa26LSL-tdTomato mice (Fig. 6D), which allow tracing of cells arising from yolk sac 17 
haematopoiesis (52). Similar results were obtained with CD209b+Tim4+ macrophages in the pleural cavity. 18 
Hence, despite being long-lived, CD209b+Tim4+ macrophages derive from conventional haematopoiesis in 19 
both sexes. Importantly, temporal analysis revealed that while little difference in abundance of CD209b-20 
expressing CD102+ macrophages was seen in pre-pubescent (4-5-week-old) male and female mice, these 21 
cells accumulated progressively in the cavity of female mice following sexual maturation. This did not 22 
occur in male mice, consistent with their higher rate of replenishment from the bone marrow and indicating 23 
that acquisition of CD209b expression appears to be associated with time-of-residency in the female cavity 24 
(Fig. 6E). Similarly, enrichment of cells expressing other markers of cluster 5, such as VSIG4, became 25 
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apparent in females with age (Fig. S7B) suggesting numerous cluster 5 genes may be regulated by time-of-1 
residency.  2 
Not all dimorphic features of peritoneal CD102+ macrophages were influenced by their rate of 3 
replenishment. For instance, the intrinsically higher expression of CXCL13 by female macrophages was 4 
not altered by CCR2 deficiency (Fig. 6F). In parallel, although we confirmed previous findings of a clear 5 
dimorphism in the numbers of B1 cells between adult male and female mice (15) and this developed 6 
gradually following sexual maturation (Fig. S7C), this phenomenon remained in Ccr2–/– mice (Fig. 6G). 7 
Similarly, while the higher levels of proliferation by male CD102+ macrophages developed following sexual 8 
maturation (Fig. 6H), this was unaffected by CCR2 deficiency (Fig. 6I). This evidence that certain 9 
dimorphic features are driven by environmental factors, independent of cell replenishment was supported 10 
further by the fact that macrophages derived from female BM in the cavity of chimeric male mice showed 11 
levels of proliferation that were identical to those of male BM derived macrophages in the male cavity and 12 
were higher than those of female BM derived macrophages in female cavity (Fig. 6J). Thus, the differential 13 
proliferation of female and male macrophages is not due to cell-intrinsic differences in their proliferative 14 
activity. 15 
Taken together these data demonstrate that both local imprinting and differential rate-of-16 
replenishment contribute to the sexual dimorphisms seen in peritoneal macrophages. 17 
 18 
 19 
Differential CD209b expression confers an advantage on female macrophages in the setting of 20 
pneumococcal peritonitis 21 
We postulated that differential expression of key pattern recognition receptors such as CD209b might 22 
endow female macrophages with an enhanced ability to deal with bacterial infection. To test this idea, we 23 
examined the acute peritonitis caused by infection with the gram-positive bacterium Streptococcus 24 
pneumoniae (Fig. 7A). At low doses, resident macrophages, and in particular CD209b, are indispensable 25 
for protective immunity in this model (53, 54) whereas  recruitment of neutrophils is not required (53) and 26 
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hence avoids any confounding effects of systemic sex-dependent effects on innate immune responses that 1 
have been reported previously (55). As CD209b is expressed exclusively by CD102+ macrophages in the 2 
peritoneal cavity (Fig. S6A), this model allowed us to directly assess the importance of differential CD209b 3 
expression by CD102+ macrophages in bacterial elimination. Strikingly, females showed enhanced 4 
capability to control S. pneumoniae infection, with lower levels of bacteria in peritoneal fluid of female 5 
mice compared with their male counterparts 20hrs after inoculation (Fig. 7B). Fewer neutrophils and Ly6Chi 6 
monocytes were present in the female cavity compared with male mice (Fig. 7C & Fig. S8), consistent 7 
with a model in which resident macrophages control infection (53). In contrast, while the well-documented 8 
macrophage ‘disappearance reaction’ (56) occurred in both male and female mice after infection (Fig. 7D), 9 
higher numbers of CD209b-expressing macrophages persisted in the female cavity (Fig. 7D). 10 
Administration of an anti-CD209b blocking antibody (22D1) (57) led to increased levels of bacteremia in 11 
female mice, although this did not attain statistical significance due to variance in bacterial counts in some 12 
mice in whom the macrophage ‘disappearance reaction’ was more pronounced (Fig. 7E).  13 
Thus, dimorphic expression of key immune receptors and molecules leads to differential ability to 14 
handle local bacterial infection. 15 
 16 
 17 
 18 
 19 
Discussion 20 
Understanding the extrinsic and intrinsic factors that govern tissue macrophage differentiation is a 21 
key goal in the field of macrophage biology. Here we reveal a striking effect of sex on the phenotypic and 22 
transcriptional identity of resident peritoneal macrophages and demonstrate that this contributes to the sex-23 
dependent resistance of mice to bacterial peritonitis. Moreover, we show that this arises through a 24 
combination of dimorphic microenvironmental signals and sex-dependent differences in the rate of 25 
macrophage renewal from the bone marrow.   26 
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Using classical defining markers such as F4/80, CD11b and CD102, we found peritoneal 1 
macrophages from male and female mice to be phenotypically identical. However, mRNA sequencing 2 
revealed marked dimorphism in the transcriptional fingerprint of resident peritoneal macrophages under 3 
homeostatic conditions. Importantly, female CD102+ macrophages expressed higher levels of genes 4 
associated with lipid uptake and transport as well as immune defence/response. In contrast, the signature of 5 
male peritoneal macrophages was dominated by cell cycle associated genes consistent with their elevated 6 
levels of proliferation, a dimorphism we have reported previously (21). Although others have reported 7 
dimorphic expression of TLRs and CD14 by peritoneal macrophages (38, 39), we found no significant 8 
difference in mRNA transcripts of the adaptor protein MyD88, CD14 or any TLRs, consistent with more 9 
recent analysis of mRNA (44) and protein expression (55).  10 
Despite a significant degree of transcriptional difference at the population level, single cell mRNA 11 
sequencing showed that male and female resident CD102+ macrophages encompassed three 12 
transcriptionally-defined clusters of cells. Of these, the cells in cluster 3 expressed CD102 together with 13 
MHCII, RELMa and CX3CR1, all of which are key markers of F4/80loMHCII+ peritoneal macrophages, 14 
suggesting that cluster 3 may be recently derived from the F4/80loMHCII+ macrophage population that is 15 
derived from blood monocytes in adult mice (21-23). As cells in cluster 4 shared features with both the 16 
MHCII-defined cluster 3 and the dominant cluster 5 population of Tim4+ macrophages, these may represent 17 
a further intermediate differentiation state. Consistent with this idea,  Tim4– cells were largely ablated in 18 
monocytopenic Ccr2–/– mice. A linear-developmental relationship that culminates at cluster 5 would be 19 
consistent with the greater abundance of cells in this cluster in females, given the slower entry of bone-20 
marrow-derived cells into the female CD102+ macrophage pool. However, it seems unlikely that such a 21 
linear developmental relationship between clusters exists in males, as Tim4 and MHCII defined subsets 22 
were found to be replenished at similarly high rates. Hence, what dictates cluster identity in males remains 23 
unclear.  24 
Given that the rate of replenishment from BM was markedly different between the sexes, a finding 25 
consistent with recent monocyte fate mapping using Ms4a3Cre.Rosa26LSL-tdTomato mice (58), this raised the 26 
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possibility that transcriptional differences could reflect different ontogenies of male and female peritoneal 1 
macrophages. Indeed, a number of the genes we found to be expressed more highly by female peritoneal 2 
macrophages, including Colec12, Cd163, Bmpr1a, Cdc42bpa, Timd4, Apoc1, and members of the Cd209 3 
family have been reported to be expressed by embryonically, but not monocyte-derived macrophages in 4 
other tissues (26, 59). However, the fact that a proportion of BM-derived peritoneal macrophages can 5 
acquire the expression of at least some of these “embryonic” signature markers (e.g. Tim4, CD209b) in the 6 
setting of tissue-protected BM chimeras, suggests that this is more likely related to their time-of-residency 7 
rather than rigid differences related to origin. Consistently, co-expression of Tim4 and CD209b identifies 8 
the longest-lived macrophages in the peritoneal cavity irrespective of sex. The concept that macrophages 9 
require prolonged residence within the tissue to acquire their characteristic features is consistent with work 10 
from the Guilliams lab showing that acquisition of Tim4 expression by monocyte-derived cells that engraft 11 
in the liver following deletion of endogenous Kupffer cells increases with time (26). Notably, human 12 
peritoneal macrophages that align with mouse F4/80hi macrophages exhibit high expression of TIMD4, 13 
CD209, COLEC12, CD163 and APOC1 (60), suggesting these may represent phylogenetically conserved 14 
markers of long-lived macrophages. Importantly, certain dimorphisms (e.g. proliferation and CXCL13 15 
expression) appeared to be regulated independently of replenishment kinetics, consistent with previous data 16 
showing that the proliferative capacity of macrophages is determined by signals in the local 17 
microenvironment rather than their origin (21, 26, 61)While our ovariectomy studies clearly implicate the 18 
ovaries and/or their products in controlling lower levels of replenishment in females, it seems unlikely that 19 
estradiol plays a key role, as administration of exogenous estradiol failed to rescue the effects of OVX. In 20 
addition, estradiol is unlikely to be responsible for the lower proliferation of female peritoneal 21 
macrophages, as estradiol is reported to increase rather than inhibit proliferation of these cells (37). 22 
Nevertheless, although expression of receptors for progesterone and androgens did not differ between the 23 
sexes, we cannot categorically rule out a role for these steroids in generating sex dimorphisms.  Thus, the 24 
exact local factor(s) driving the sex dimorphisms identified here remain to be elucidated. 25 
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 The incidence and severity of sepsis and post-surgical infections are profoundly lower in women 1 
than men (67), but the mechanisms underlying these differences remain unclear. Our finding that female 2 
mice are more resistant to S. pneumoniae peritonitis is consistent with previous work on group B 3 
streptococcal peritonitis (39). However, while others attributed this to other elements of innate immune 4 
responses, such as neutrophil recruitment (55), our data suggest that the resistance of females is at least, in 5 
part, due to differences in resident peritoneal macrophages, such as elevated expression of CD209b. 6 
However, we cannot rule out other mechanisms, such as dimorphic expression of CXCL13 which plays a 7 
central role in recruiting natural IgM-producing B1 cells (2) (62, 63), or elevated expression of complement 8 
components C1q, C3, and C4b, as well as Cfb that are essential for innate resistance to against S.pneumoniae 9 
(62-64). Nonetheless, we propose that this heightened barrier function in the female peritoneum may have 10 
evolved to mitigate the risk of sexually transmitted infection disseminating from the lower female 11 
reproductive tract (65) or to protect against puerperal peritonitis.  12 
Our studies highlight the importance of taking age and sex into account when understanding the 13 
peritoneal response to disease and implicate time-of-residency as an underlying determinant of resident 14 
macrophage function. Further work is needed to understand the molecular processes that underlie the 15 
requirement for time-of-residency on expression of these genes and to identify the local signals that govern 16 
this process. Beyond the cavity, our findings also have wider implications for the molecular mechanisms 17 
that drive dimorphic production of natural IgG by peritoneal B1 cells that provides women and infants with 18 
heightened resistance to blood-borne bacterial infections, particularly as these antibodies are lost in the 19 
absence of peritoneal macrophages (15).  20 
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Materials and methods 1 
Study Design 2 
We performed phenotypic, transcriptomic and functional analysis of peritoneal macrophages to identify 3 
sexual dimorphisms that may exist. We used tissue-protected bone marrow chimeric mice and genetic fate 4 
mapping to assess the replenishment kinetics under normal physiological conditions. To assess the role for 5 
sex hormones in generating/maintaining sex dimorphisms, we performed ovariectomy in C57BL/6 mice. 6 
To assess macrophage function in the context of infection, we used a model of low dose Streptococcus 7 
pneumoniae infection (51). 8 
 9 
Experimental Animals  10 
Wild type C57BL/6J CD45.2+, congenic CD45.1+CD45.2+ mice, Ccr2–/–, Rag1–/– and Balb/c mice were 11 
bred and maintained in SPF facilities at the University of Edinburgh, UK. In some experiments, C57BL/6J 12 
(Crl) mice were purchased from Charles River, UK or bred and maintained at the University of Manchester, 13 
while Ccr2–/–,  Rag1–/– and control mice were bred and maintained at the University of Glasgow. ItgaxCre 14 
(66) (referred here to CD11cCre) mice were crossed with Rosa26LSL-YFP mice (a gift from Dr. Megan Mcleod, 15 
University of Glasgow, UK) and maintained at the University of Glasgow. For Cdh5Cre-ERT2 fate mapping, 16 
WT females aged 6-10 weeks were subjected to timed matings 17 
with Cdh5CreERT2+/− or Cdh5CreERT2+/+ Rosa26tdT/tdTCx3cr1gfp/gfp males (experiments performed at CIML, 18 
Marseille, France). Successful mating was judged by the presence of vaginal plugs the morning after, which 19 
was considered 0.5days post conception. For induction of reporter recombination in the offspring, a single 20 
dose of 4-hydroxytamoxifen (4OHT; 1.2mg) was delivered by i.p. injections to pregnant females at E7.5. 21 
To counteract adverse effects of 4OHT on pregnancy, 4OHT was supplemented with progesterone (0.6mg). 22 
In cases when females could not give birth naturally, pups were delivered by C-section and cross-fostered 23 
with lactating CD1 females. All experimental mice were age and sex matched. To perform estrous staging, 24 
vaginal lavage was performed and cellular content examined following haematoxylin and eosin staining, 25 
as previously described (67). For high fat diet (HFD) experiments, tissue protected BM chimeric mice were 26 
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placed on HFD (58 kcal% fat and sucrose, Research Diet, D1233li) for 8 weeks starting 4 weeks post 1 
reconstitution. Experiments performed at UK establishments were permitted under license by the UK Home 2 
Office and were approved by the University of Edinburgh and University of Manchester Animal Welfare 3 
and Ethical Review Body’s or the University of Glasgow Local Ethical Review Panel. 4 
 5 
Surgery.  6 
Ovariectomy was performed on 6-week-old wild type (C57BL/6J) or tissue protected BM chimeras 8 weeks 7 
post-reconstitution (16 weeks of age). Briefly, dorsal unilateral or bilateral ovariectomy (OVX) was 8 
performed and mice allowed to recover for up to 8 weeks. Sham surgery was performed to control for the 9 
effects of surgery on the peritoneal environment. This involved identical surgery except for the excision of 10 
the ovary/ovaries. Surgery was performed under isoflurane anaesthesia followed by a postoperative 11 
analgesic, buprenorphine (0.1 mg/kg), for pain management. In some experiments following 7 days of 12 
recovery, mice received exogenous estradiol in the form of E2 valerate (E2;  0.01 mg/kg) s.c. thrice weekly 13 
for 3 weeks.  14 
 15 
Tissue-protected BM chimeric mice. Anaesthetised 6-12 week old C57BL/6J CD45.1+CD45.2+ animals 16 
were exposed to a single dose of 9.5 Gy g-irradiation, with all but the head and upper thorax of the animals 17 
being protected by a 2 inch lead shield. Animals were subsequently given 2-5×106 BM cells from sex 18 
matched or mismatched congenic CD45.2+ C57BL/6J animals by i.v. injection. Unless specified, mice were 19 
left for a period of at least 8 weeks before analysis of chimerism in the tissue compartments. 20 
 21 
BrdU injection. For labelling of proliferating cells, mice were injected s.c. with 100µl of 10mg/ml BrdU 22 
(Sigma) in Dulbecco’s PBS 2hr before culling.  23 
 24 
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Preparation of single cell suspensions. Mice were sacrificed by CO2 inhalation or by terminal anaesthesia 1 
followed by exsanguination. Peritoneal and pleural cavities were lavaged with RPMI containing 2mM 2 
EDTA and 10mM HEPES (both Invitrogen) as described previously (68). Any samples with excessive 3 
erythrocyte contamination were excluded from analysis. Omental tissue was excised, chopped finely and 4 
digested in 0.5ml pre-warmed collagenase D (1mg/ml; Roche) in RPMI 1640 media supplemented with 2% 5 
FCS for 15 minutes in a shaking incubator at 37°C. Following disaggregation with a P1000 Gilson, omental 6 
tissue was digested for a further 20mins before being placed on ice. 2.5µl of 0.5M EDTA was added to 7 
each sample to inhibit enzymatic activity. Cell suspensions were passed through an 100µm filter and 8 
centrifuged at 1700rpm for 10mins. The resulting cell suspension was subsequently passed through a 40µm 9 
strainer prior to cell counting. All cells were maintained on ice until further use. Cellular content of the 10 
preparations was assessed by cell counting using a Casey TT counter (Roche) in combination with multi-11 
colour flow-cytometry.  12 
 13 
Flow cytometry. Equal numbers of cells were blocked with 0.025 µg anti-CD16/32 (2.4G2; Biolegend) and 14 
1:20 heat-inactivated mouse serum (Invitrogen), and then stained with a combination of the antibodies 15 
detailed in Supplementary Table 8. Where appropriate, cells were subsequently stained with 16 
streptavidin-conjugated fluorochromes. Dead cells were excluded using DAPI, 7-AAD or Zombie Aqua 17 
fixable viability dye (Biolegend). Fluorescence-minus-one (FMO) controls confirmed gating strategies, 18 
while discrete populations within lineage+ cells were confirmed by omission of the corresponding 19 
population-specific antibody. Erythrocytes in blood samples were lysed using 1x RBC Lysis buffer 20 
(Biolegend), as per the manufacturer’s guidelines. For intracellular staining, cells were subsequently fixed 21 
and permeabilized using FoxP3/Transcription Factor Staining Buffer Set (eBioscience), and intracellular 22 
staining performed using antibodies detailed in Supplementary Table 2. For the detection of BrdU, cells 23 
were fixed as above and incubated with 3µg DNaseI (Sigma) for 30-60mins, before being washed in 24 
PermWash (eBioscience) and then incubated with anti-BrdU antibody for 30mins at RT. Samples were 25 
acquired using a FACS LSRFortessa or AriaII using FACSDiva software (BD) and analyzed with FlowJo 26 
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software (version 9 or 10; Tree Star). Analysis was performed on single live cells determined using forward 1 
scatter height (FCS-H) versus area (FSC-A) and negativity for viability dyes. For analysis of macrophage 2 
proliferation, Ki67 expression was used to determine the frequency of all CD102+/F4/80hi cells in cycle, 3 
whereas a 2h BrdU pulse before necropsy combined with Ki67 expression was used to identify cells in S 4 
phase, as described previously (69). mRNA was detected by flow cytometry using PrimeFlow technology 5 
(ThermoFisher) using probes against ApoE (probe type 10; AF568), ApoC1 (probe type 4; AF488) and 6 
CXCL13 (probe type 6; AF750) according to the manufacturer’s guidelines. For staining controls in 7 
PrimeFlow analysis, the Target Probe Hybridization step was omitted with all other steps identical to 8 
samples.  9 
 10 
Transcriptional Analysis.  11 
Bulk RNAseq 12 
CD102+F4/80hi cells were FACS-purified from the peritoneal and pleural cavities of unmanipulated male 13 
and female mice. For each population, 25,000 cells were sorted into 500µl RLT buffer (Qiagen) and snap 14 
frozen on dry ice. RNA was isolated using the RNeasy Plus Micro kit (Qiagen), at which point triplicates 15 
of 25,000 cells for each population were pooled. 10 ng of total RNA were amplified and converted to cDNA 16 
using Ovation RNASeq System V2 (Nugen). Sequencing was performed by Edinburgh Genomics using  17 
the Illumina HiSeq 4000 system (75PE). Raw map reads were processed with the R package DESeq2 (70) 18 
to generate the differentially expressed genes, and the normalized count reads to generate and visualize on 19 
heat maps generated by the R package pheatmap. Samples with >5% of reads mapped to ribosomal RNA 20 
were removed from analysis. DEG were determined using at least a 1.5-fold difference and adjusted p < 21 
0.01, for each of the six pairwise comparisons. Pathway enrichment analysis was performed using the 22 
GSEA online database and the R package gskb (Gene Set data for pathway analysis in mouse) which makes 23 
predictions between each of the six pairwise comparisons, incorporating in the analysis the statistically 24 
significant differences in gene expression. The R package gskb was used to determine the chromosomal 25 
location of each of the genes and transcription factors. All R code is available upon request. 26 
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 1 
Single-cell RNAseq 2 
10K cells for male and female sorted cells were loaded in Chromium 10x in parallel. Libraries were 3 
prepared as per manufacturer’s protocol and sequenced on Illumina Novaseq S1. Initial processing was 4 
done using Cellranger (v2.1.1) mkfastq and count (aligned to mouse assembly mm10). Preparation of 5 
analysis ready data: For each dataset (filtered data from Cell Ranger pipeline), we filtered out potentially 6 
low quality cells using dataset-specifc thresholds based on the trend of the number of genes per cell versus 7 
number of housekeeping genes per cell and number of genes per cell versus percentage of mitochondrial 8 
genes per cell curves as follows. More specifically, for the female data, we retained 4341 cells that have 9 
between 300 and 5000 genes, at least 65 housekeeping genes and percentage of mitochondrial genes over 10 
the total number of expressed genes below 2%. For the male data, we retained 2564 cells that have between 11 
300 and 6000 genes, at least 70 housekeeping genes and percentage of mitochondrial genes over the total 12 
number of expressed genes below 2%. Finally, we filtered out genes that were expressed in less than 1% of 13 
the cells from each dataset. Clustering analysis of the data: 14 
Clustering and data merging using CCA was done using Seurat (v3.1.0). We used default parameters and 15 
20 principal components for aligning and clustering the data. We next removed a very small cluster that lay 16 
far from all other clusters on the UMAP projection, indicating it could be either contamination or doublets 17 
and constructed a phylogenetic tree of the remaining clusters to understand the distances and relationship 18 
between them. Clusters that were closely grouped together and did not show unique markers, were merged 19 
together. The final result consists of 6890 cells grouped into 6 clusters. Identification of differentially 20 
expressed genes in CCA aligned clusters: We used MAST (v1.10) as implemented in the Seurat package 21 
and with default parameters to identify differentially upregulated genes between the identified clusters. To 22 
overcome the bias of batch effect, we found differentially upregulated genes within each dataset separately 23 
and retained the intersection of markers (conserved markers). Identification of differentially expressed 24 
genes between female and male cells: We used Student’s t-test as implemented in the Seurat package 25 
between equivalent female and male cells to identify differentially upregulated genes between male and 26 
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female cells. We only retained genes with adjusted p-value based on Bonferroni correction below 0.05. For 1 
definition of cluster-specific differentially expressed genes, overlap with expression in cluster 6 was 2 
ignored given that this cluster was defined by proliferation and hence comprised cells from across other 3 
clusters.   4 
S. pneumoniae peritonitis.  5 
S. pneumoniae were cultured overnight on blood agar plates (5% CO2, 95% air, 37 C), inoculated into 6 
Brain Heart Infusion broth, cultured for 3 h, washed, and resuspended at 104 CFU/ ml (estimated by OD595) 7 
in sterile PBS. Their concentration was verified by serial dilution and culture on blood agar plates. Groups 8 
of male and female, age-matched C57Bl/6 mice (8–14 wk of age) were inoculated intraperitoneally with 9 
100 µl of PBS containing 103 CFU S. pneumoniae (capsular type 2 strain D39). Mice were culled 20 h later 10 
and peritoneal lavage performed using sterile PBS. 100 µl of lavage fluid was cultured for bacterial growth 11 
for 24 h. The remaining lavage fluid was centrifuged at 400g for 5 mins and the resulting cells counted and 12 
prepared for flow cytometric analysis.  13 
Statistics. Statistics were performed using Prism 7 (GraphPad Software). The statistical test used in each 14 
experiment is detailed in the relevant figure legend. 15 
  16 
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Figure 1. Environment drives sexual dimorphism in macrophage replenishment in the peritoneal 1 
cavity 2 
(A) Expression of CD11b and CD3, CD19, Ly6G and SiglecF (‘Lineage’) by live CD45+ peritoneal 3 
leukocytes (left) and expression of CD102 and MHCII by CD11b+ Lin– cells (centre) from adult C57Bl/6 4 
female mice. Histograms show expression of F4/80 and CSF1R by CD102+ and CD102–MHCII+ cells (also 5 
see Fig. S1A). (B) Scheme for the generation of sex mis-matched, tissue-protected bone marrow (BM) 6 
chimeric mice. (C-D) Representative chimerism (C) and  normalized non-host chimerism (D) of 7 
peritoneal F4/80hiCD102+ macrophages from sex matched or mismatched tissue protected BM chimeric 8 
mice 8-12 weeks post-reconstitution (also see Fig. S1B). Data are normalised to the non-host chimerism 9 
of Ly6Chi monocytes. **P<0.01, ****P<0.0001 One-way ANOVA. Data represent 9 10 
(female>male) or 10 (sex matched) mice per group pooled from two independent experiments. (E) 11 
Gating strategy to identify macrophages amongst omental isolates (also see Fig. S1D). (F) 12 
Normalized non-host chimerism of omental Ly6C+ monocytes and CD102-defined macrophages 13 
from mice in (D). Data are normalised to the non-host chimerism of Ly6Chi monocytes. Data 14 
represent 7 (female > female), 8 (female > male) or -9 (male > male) mice per group pooled from 15 
two independent experiments. *P<0.05. One-way ANOVA. Symbols represent individual animals 16 
and horizontal bars represent the mean. 17 
  18 
 
Figure 2. Sexual dimorphism in peritoneal macrophage replenishment occurs following sexual 1 
maturity 2 
(A) Experimental scheme of CD11cCre.Rosa26LSL-eYFP fate-mapping mice. 3 
(B) Representative expression of eYFP by peritoneal F4/80hiCD102+ macrophages from male and female 4 
CD11cCre.Rosa26LSL-eYFP fate-mapping mice at 4 and 16 weeks of age. Right, frequency of eYFP+ cells 5 
amongst F4/80hiCD102+ macrophages in male and female mice at the indicated ages. Symbols represent 6 
individual animals and horizontal bars represent the mean. Data represent 4 (male 4 weeks), 5 (female 4 7 
weeks), 6 (male 16 weeks) or 9 (female 16 weeks) mice per group pooled from two independent 8 
experiments. For upstream gating strategy see Fig. S2A. 9 
(C) Expression of CD11c by peritoneal F4/80hiCD102+ macrophages from male and female and CD102–10 
MHCII+ cells from female mice.  11 
(D) Representative expression of eYFP by pleural F4/80hiCD102+ macrophages from male and female 12 
CD11cCre.Rosa26LSL-eYFP fate-mapping mice at 4 and 16 weeks of age. Right, frequency of eYFP+ cells 13 
amongst pleural F4/80hiCD102+ macrophages in male and female mice at the indicated ages. Symbols 14 
represent individual animals and horizontal bars represent the mean. Data represent 3 (male 16 weeks), 5 15 
(female 4 & 16 weeks) or 6 (male 4 weeks) per group pooled from two independent experiments. 16 
 17 
 18 
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Figure 3. Ovariectomy leads to increased macrophage replenishment 1 
(A) Representative images of the uterine horns of tissue-protected BM chimeric mice that had received 2 
unilateral or bilateral oophorectomy (OVX), sham surgery or were completely unmanipulated (control).  3 
(B) Absolute number of F4/80hiCD102+ macrophages and CD102–MHCII+ cells obtained from the 4 
peritoneal cavity of tissue-protected BM chimeric mice that had received surgery 8 weeks earlier. Symbols 5 
represent individual animals and horizontal bars represent the mean. Data represent 9 (sham) or 10 (control, 6 
unilateral, bilateral) mice per group pooled from two independent experiments. For upstream gating strategy 7 
see Fig. S2B. 8 
(C) Non-host chimerism of blood Ly6Chi blood monocytes (left) and F4/80hiCD102+ macrophages obtained 9 
from the peritoneal (centre) or pleural (right) cavity of tissue-protected BM chimeric mice that had received 10 
surgery 8 weeks earlier. Symbols represent individual animals and horizontal bars represent the mean. Data 11 
represent 9 (sham) or 10 (control, unilateral, bilateral) mice per group pooled from two independent 12 
experiments. **P<0.01, ***P<0.001, ****P<0.0001. One-way ANOVA with Tukey’s multiple 13 
comparisons test. 14 
(D) Frequency of Tim4– cells amongst F4/80hiCD102+ macrophages obtained from the peritoneal (centre) 15 
or pleural (right) cavity of mice in (B). ***P<0.001, ****P<0.0001. One-way ANOVA with Tukey’s 16 
multiple comparisons test. For representative FACS plots see Fig. S2C. 17 
(E) Frequency of Tim4– cells amongst F4/80hiCD102+ macrophages obtained from the peritoneal cavity of 18 
unmanipulated C57Bl/6 female mice (controls) or age-matched females that received bilateral OVX or 19 
sham surgery 4 weeks earlier. One group received exogeneous estradiol (E2) thrice weekly for 3 weeks. 20 
Symbols represent individual animals and horizontal bars represent the mean. Data represent 8 (control) or 21 
10 (sham, bilateral, bilateral + E2) mice per group pooled from two independent experiments. *P<0.05, 22 
**P<0.01, ***P<0.001, ****P<0.0001. One-way ANOVA with Tukey’s multiple comparisons test. 23 
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Figure 4: Sex determines the transcriptional signature of peritoneal macrophages 1 
(A) Heatmap showing distance between samples of male (M) and female (F) CD102+F4/80hi macrophages 2 
FACS-purified from the peritoneal cavity of 10-12 week old mice. 3 
(B) Gene expression profile of the 148 differentially expressed (>1.5 fold) genes between male and female 4 
peritoneal macrophages with selected genes highlighted.  5 
(C) Expression of Cd209b from RNAseq (FPKM; left panel), representative expression of CD209b protein 6 
(middle panels) and frequency of CD209b+ cells amongst CD102+F4/80hi peritoneal macrophages obtained 7 
from 10-12-week-old male or female C57BL/6 mice (right panel) and the mean fluorescence intensity 8 
(MFI) of CD209b expression by these cells (far right panel). Symbols represent individual animals and 9 
horizontal bars represent the mean. RNAseq data represent 3 mice per group and protein analysis represents 10 
5 mice per group from one of five independent experiments. ****P<0.0001. Student’s t test. For gating 11 
strategy see Fig. S5C.  12 
(D) Expression of Cxcl13 from RNAseq (FPKM; left panel), representative expression of CXCL13 mRNA 13 
(middle panels) and frequency of CXCL13+ cells amongst CD102+F4/80hi peritoneal macrophages obtained 14 
from 10-12-week-old male or female C57BL/6 mice (right panel) and the mean fluorescence intensity 15 
(MFI) of CXCL13 mRNA expression by these cells (far right panel). Symbols represent individual animals 16 
and horizontal bars represent the mean. RNAseq data represent 3 mice per group and flow cytometric 17 
analysis represents 5 mice per group from one of three independent experiments. *P<0.05, ***P<0.001. 18 
Student’s t test. 19 
(E) Expression of Apoc1 from RNAseq (FPKM; left panel), representative expression of ApoC1 mRNA 20 
(middle panels) and frequency of ApoC1+ cells amongst CD102+F4/80hi peritoneal macrophages obtained 21 
from 10-12-week-old male or female C57BL/6 mice (right panel) and the mean fluorescence intensity 22 
(MFI) of ApoC1 mRNA expression by these cells (far right panel). Symbols represent individual animals 23 
and horizontal bars represent the mean. RNAseq data represent 3 mice per group and flow cytometric 24 
 
analysis represents 5 mice per group from one of three independent experiments. *P<0.05, ***P<0.001. 1 
Student’s t test. 2 
(F) Expression of Apoe from RNAseq (FPKM; left panel), representative expression of ApoE mRNA 3 
(middle panels) and frequency of ApoE+ cells amongst CD102+F4/80hi peritoneal macrophages obtained 4 
from 10-12-week-old male or female C57BL/6 mice (right panel) and the mean fluorescence intensity 5 
(MFI) of ApoE mRNA expression by these cells (far right panel). Symbols represent individual animals 6 
and horizontal bars represent the mean. RNAseq data represent 3 mice per group and flow cytometric 7 
analysis represents 5 mice per group from one of three independent experiments. *P<0.05, ***P<0.001. 8 
Student’s t test. 9 
(G) Expression of Mki67 from RNAseq (FPKM; left panel), representative expression of Ki67 protein and 10 
BrdU incorporation (middle panels) and the frequency of BrdU+Ki67+ cells amongst CD102+F4/80hi 11 
peritoneal macrophages obtained from 10-12-week-old male or female C57BL/6 mice. Symbols represent 12 
individual animals and horizontal bars represent the mean. Data represent 5 mice per group from one of 13 
two experiments. ***P<0.001. Student’s t test. 14 
(H) Expression of Retnla from RNAseq (FPKM; left panel), representative expression of RELMa protein 15 
(middle panels) and the frequency of RELMa+ cells amongst CD102+F4/80hi peritoneal macrophages 16 
obtained from 10-12-week-old male or female Rag1–/– C57BL/6 mice. Symbols represent individual 17 
animals and horizontal bars represent the mean. *P<0.05, ***P<0.001. Student’s t test. 18 
 19 
 20 
 21 
Figure 5: scRNAseq analysis reveals dimorphic macrophage heterogeneity 22 
(A) UMAP dimensionality reduction analysis of 4341 and 2564 number of cells from the peritoneal 23 
cavity of 19 week-old male or female mice identifying 6 clusters. 24 
 
(B) UMAP profile of female and male peritoneal cells. 1 
(C) Feature plots displaying expression of individual genes by merged female/male cells. 2 
(D) Heatmap displaying the 10 most differentially expressed genes by each cluster from A (select genes 3 
highlighted).  4 
(E) Relative frequency of each cluster in the female and male dataset. 5 
(F)  Representative expression of Ki67 and BrdU incorporation by CD102+ macrophages (top panels), 6 
expression of Tim4 by Ki67– CD102+ macrophages (middle panels), and expression of MHCII by Tim4– 7 
CD102+ peritoneal macrophages from 10-12 week old male or female C57BL/6 mice.  8 
(G) Relative frequency of each cluster as a proportion of all CD11b+ cells determined by flow cytometry 9 
in F. 10 
(H) Expression of Apoc1 (mRNA), CXCL13 (mRNA) and CD209b protein by CD102loMHCII+ and 11 
Tim4/MHCII-defined CD102+ peritoneal macrophages from 10-12 week old male or female C57BL/6 12 
mice. Data represent 8 (male) and 10 (female) mice per group pooled from three independent experiments. 13 
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. One-way ANOVA with Tukey’s multiple comparisons 14 
test. 15 
 (I)  Histograms show representative expression of FRb by CD102loMHCII+ and Tim4-defined CD102+ 16 
peritoneal macrophages from 10-12 week old male or female C57BL/6 mice. Scatter plot show frequency 17 
of FRb+ cells amongst CD102loMHCII+ and Tim4/MHCII-defined CD102+ peritoneal macrophages. Data 18 
represent 6 (female) or 7 (male) mice per group pooled from two independent experiments. *P<0.05, 19 
**P<0.01, ***P<0.001, ****P<0.0001. One-way ANOVA with Tukey’s multiple comparisons test. 20 
(J) Expression of RELMa by CD102loMHCII+ and Tim4/MHCII-defined CD102+ peritoneal macrophages 21 
from 10 week old male or female C57BL/6 mice. Data represent 3 mice per group from one of at least 5 22 
independent experiments **P<0.01, ***P<0.001, ****P<0.0001. One-way ANOVA with Tukey’s multiple 23 
comparisons test. 24 
 	
(K) Frequency of ApoE+ (mRNA) cells amongst CD102loMHCII+ and Tim4/MHCII-defined CD102+ 1 
peritoneal macrophages (left) and mean fluorescence intensity of ApoE by these subsets (right) from 10-2 
12 week old male or female C57BL/6 mice. Data represent 8 (male) and 10 (female) mice per group 3 
pooled from three independent experiments. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. One-way 4 
ANOVA with Tukey’s multiple comparisons test. 5 
 6 
(L) Expression of CX3CR1-GFP by CD102loMHCII+ and Tim4/MHCII-defined CD102+ peritoneal 7 
macrophages from 15 week old male or female Cx3cr1+/gfp mice. Data represent 5 (female) or 7 (male) 8 
mice per group pooled from three independent litters. ****P<0.0001. One-way ANOVA with Tukey’s 9 
multiple comparisons test. 10 
 (M) Frequency of eYFP+ cells amongst F4/80, MHCII and Tim4-defined macrophages obtained from 16-11 
week-old male and female CD11cCre.Rosa26LSL-eYFP mice. Symbols represent individual animals and 12 
horizontal bars represent the mean. Data represent 5 (male) or 9 (female) mice per group pooled from two 13 
independent experiments. 14 
(N) Relative mean fluorescence intensity of Tim4 expression by Tim4+ CD102+ peritoneal macrophages 15 
from 10-12 week old male or female C57BL/6 mice. Data represent 8 (male) or 11 (female) mice per group 16 
pooled from three independent experiments. *P<0.05. Mann Whitney test.  17 
 

Figure 6: Differential replenishment and environmental signals drive the dimorphic features of 1 
peritoneal macrophages 2 
(A) Frequency of Tim4–, RELMa+, and MHCII+ and RFb+ cells amongst CD102+ macrophages from the 3 
peritoneal cavity of unmanipulated age-matched Ccr2+/+ or Ccr2–/– mice. Symbols represent individual 4 
animals and horizontal bars represent the mean. Data are pooled from two independent experiments. Tim4 5 
data represents 3 (Ccr2+/+ males), 6 (Ccr2+/+ females) or 7 (Ccr2–/–) 22-28 week old mice per group. RELMa 6 
data represent with 13 male and 9 female 14-18 week old mice per group. MHCII data represent 4 (Ccr2+/+ 7 
males), 6 (Ccr2+/+ females) or 7 (Ccr2–/–) 22-28 week old mice per group. FRb data represent 6 (Ccr2+/+ 8 
males), 8 (Ccr2–/– females) or 9 (Ccr2+/+ females and Ccr2–/– males) 13 week old mice per group. *P<0.05, 9 
**P<0.01, ****P<0.0001. Student’s t test with Holm-Sidak correction. 10 
(B) Representative expression of ApoE by CD102+ macrophages (histograms) and frequency of ApoE–, 11 
CD209b+ and ApoC1+ cells from the peritoneal cavity of unmanipulated age-matched Ccr2+/+ or Ccr2–/– 12 
mice. Symbols represent individual animals and horizontal bars represent the mean. Data are pooled from 13 
two independent experiments and represents 3 (Ccr2+/+ males), 6 (Ccr2+/+ females) or 7 (Ccr2–/–) 22-28 14 
week old mice per group. *P<0.05, **P<0.01. Student’s t test with Holm-Sidak correction. 15 
(C) Normalized non-host chimerism of CD209/Tim4-defined subsets of CD102+ macrophages from the 16 
peritoneal cavity of sex matched tissue-protected BM chimeric mice 8 weeks post-reconstitution. Data are 17 
normalised to the non-host chimerism of Ly6Chi monocytes. Data represent 5 mice per group from one 18 
experiment. *P<0.05, ***P<0.001. Paired Student’s t test.  19 
(D) Proportion of tdTomato+ (Ai14) cells amongst microglia, peritoneal and pleural macrophages from 15-20 
week-old Cdh5Cre-ERT2.Rosa26LSL-Ai14.Cx3cr1+/gfp mice administered 4-hydroxytamoxifen at E7.5. Data 21 
represent 6 (female) or 7 (male) mice per group from three independent litters. ****P<0.0001. One-way 22 
ANOVA followed by Tukey’s multiple comparisons test. 23 
 
(E) Frequency of cells expressing CD209b amongst CD102+ macrophages obtained from the peritoneal 1 
cavity of unmanipulated C57BL/6 mice of indicated ages. Symbols represent individual animals and 2 
horizontal bars represent the mean. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Two-way ANOVA 3 
with Sidak’s multiple comparisons test. 4 
(F) Frequency of cells expressing CXCL13 mRNA (left) or CXCL13 protein (right) amongst CD102+ 5 
macrophages obtained from the peritoneal cavity of unmanipulated 22-28 week old Ccr2+/+ or Ccr2–/– mice.  6 
Symbols represent individual animals and horizontal bars represent the mean. CXCL13 mRNA data 7 
represents 3 (Ccr2+/+ males), 5 (Ccr2+/+ females) or 5 (Ccr2–/–) mice per group. CXCL13 protein data 8 
represents 2 (Ccr2+/+ males), 4 (Ccr2+/+ females) or 5 (Ccr2–/–) mice per group. 9 
(G) The absolute number of B1 cells obtained from the peritoneal cavity of unmanipulated age matched 10 
14-28 week old Ccr2+/+ or Ccr2–/– mice. Data represent 15 (Ccr2+/+ females), 16 (Ccr2–/– females), 17 11 
(Ccr2+/+ males) or 20 (Ccr2–/– females) mice per group pooled from four independent experiments. 12 
 (H) Frequency of cells expressing Ki67 amongst F4/80hi macrophages obtained from the peritoneal cavity 13 
of unmanipulated C57BL/6 mice of indicated ages. Symbols represent individual animals and horizontal 14 
bars represent the mean. *P<0.05, ****P<0.0001. Two-way ANOVA with Tukey’s multiple comparisons 15 
test. 16 
(I) Frequency of Ki67+ cells amongst peritoneal F4/80hi macrophages obtained from the peritoneal cavity 17 
of unmanipulated 14-18 week old Ccr2+/+ or Ccr2–/– mice.  Data represents 15 (Ccr2+/+ females), 16 (Ccr2–18 
/– females), 17 (Ccr2+/+ males) or 20 (Ccr2–/– females) mice per group pooled from 2 experiments. 19 
 20 
(J) Frequency of Ki67+ cells amongst peritoneal F4/80hi macrophages obtained from sex matched or 21 
mismatched tissue protected BM chimeric mice 8-12 weeks post-reconstitution. Data represent 9 (female > 22 
male) or 10 (sex matched groups) mice per group pooled from one of two independent experiments. 23 
**P<0.01. One-way ANOVA followed by Tukey’s multiple comparisons test.  24 
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Fig. S1: Replenishment kinetics of peritoneal and omental leukocytes in BM chimeric mice 
(associated with Fig. 1) 
Fig. S2: Gating strategies and effects of OVX on peritoneal leukocytes (associated with Fig. 2 and 3) 
Fig. S3: Effects of high fat diet (HFD) on peritoneal macrophage replenishment kinetics 
Fig. S4: Strategy for the purification of CD102+ macrophages for RNAseq analysis (associated with 
Fig. 4) 
Fig. S5: Additional RNAseq analysis 
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strains (associated with Fig. 4) 
Fig S7: Certain sexual dimorphisms arise with age (associated with Fig. 5 and 6). 
Fig. S8: Identification of leukocytes in peritoneal fluid during S. pneumoniae-induced peritonitis 
(associated with Fig. 7). 
  
 
Fig. S1 Replenishment kinetics of peritoneal and omental leukocytes in BM chimeric mice 
(A) Gating strategy used for selection of leukocytes in Fig. 1A. (B) Gating strategy used for 
identification of leukocyte subsets in Fig. 1C and Fig. S1C. (C) Normalized non-host chimerism of 
peritoneal F4/80hiCD102+ macrophages and indicated leukocytes from sex matched tissue-protected 
BM chimeric mice 8-12 weeks post-reconstitution. Data are normalised to the non-host chimerism of 
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represent 10 mice per group pooled from two independent experiments. ****P<0.0001. Student’s t test 
with Holm-Sidak correction. (D) Gating strategy for the identification of omental macrophage subsets. 
(E) Expression of MHCII by CD102-defined macrophage subsets and CD11b+ DC from omental 
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correction. 
  
 
Fig. S2: Gating strategies and effects of OVX on peritoneal leukocytes  
(A)  Gating strategy used for identification of macrophage subsets in Fig. 2B-D. (B) Upstream gating 
for analysis in Fig. 3B-E.  (C) Representative FACS plots of data in Fig. 3D. Frequency of 
F4/80hiCD102+ macrophages (D) and CD102–MHCII+ cells (E) of total CD45+ cells obtained from the 
peritoneal cavity of tissue-protected BM chimeric mice that had received surgery 8 weeks earlier. (F-I) 
Frequency (left panels) and absolute number of eosinophils (F), B1 cells (G), B2 cells (H) and T cells 
(I) from the peritoneal cavity of tissue-protected BM chimeric mice that had received surgery 8 weeks 
earlier. Symbols represent individual animals and horizontal bars represent the mean. Data represent 9 
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(sham) or 10 (control, unilateral, bilateral) mice per group pooled from two independent experiments. 
*P<0.05, **P<0.01. One-way ANOVA with Tukey’s multiple comparisons test. 
  
 
Fig. S3: Effects of high fat diet (HFD) on peritoneal macrophage replenishment kinetics 
 (A) Experimental scheme for the generation of sex matched, tissue-protected bone marrow (BM) 
chimeric mice and high-fat diet regimen. (B) Mass of abdominal adipose tissue in male and female mice 
fed control or high fat diet for 4 weeks and rested for 8 weeks. (C) Bodyweight of male and female 
mice fed control or high fat diet for 4 weeks and rested for 8 weeks (8) paired to starting bodyweight 
(0). (D) Normalized non-host chimerism of peritoneal F4/80hiCD102+ macrophages from mice in A. 
Symbols represent individual animals and horizontal bars represent the mean. Data represent 5 (B) mice 
from one experiment or 10 (C, D) mice per group pooled from two independent experiments.  
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Fig. S4: Strategy for the purification of CD102+ macrophages for RNAseq analysis  
(A) Gating strategy for the identification and FACS-purification of CD102+ macrophages for 
population-level RNAseq. (B) Expression of F4/80 by peritoneal CD102-defined macrophages. (C) 
Representative post-sort purity of CD102-defined macrophages. 
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Fig. S5: Additional RNAseq analysis 
 (A) Expression of indicated TLRs and TLR adaptor molecules by male and female peritoneal 
macrophages in the population-level RNAseq data set. (B) Expression of selected genes by male and 
female peritoneal macrophages that were identified by Villa et al. (Cell Reports) to be expressed in a 
sexually dimorphic fashion by microglia. (C) Gating strategy for the identification of macrophage 
subsets using the PrimeFlow assay (Fig. 4D-F). 
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Fig. S6: Sexual dimorphisms are present in mice from different housing environments and across 
strains  
(A) Representative expression of CD102 and CD209b by peritoneal all CD45+ leukocytes obtained 
from age-matched male and female C57BL/6 mice. (B) Representative expression of Tim4 and CD209b 
by peritoneal CD102+ macrophages obtained from age-matched male and female C57BL/6 mice housed 
at the indicated institutions. (C) Representative expression of Tim4 and CD209b by peritoneal CD102+ 
macrophages obtained from age-matched male and female Rag1–/– mice (left) and frequency of 
CD209b+Tim4+ macrophages, the relative mean fluorescence intensity (MFI; normalised to female cells) 
of CD209b and frequency of Tim4– macrophages in each sex. Data are pooled from two independent 
experiments with 8 (female) or 10 (male) mice per group. ****P<0.0001. Student’s t test. (D) 
Representative expression of CD209b, Tim4 and Ki67 by peritoneal CD102+ macrophages obtained 
from age-matched male and female BALB/c mice (left) and a summary of replicate data showing the 
frequency of CD209b+, Tim4+ and Ki67+ cells as well as MFI of expression. Data are pooled from two 
independent experiments with 9 mice per group. *P<0.05, ** P<0.01, ***P<0.001, ****P<0.0001. 
Student’s t test or Mann-Whitney test (Ki67). 
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Fig S7: Certain sexual dimorphisms arise with age  
(A) Expression of VSIG4 protein by CD102loMHCII+ and Tim4/MHCII-defined CD102+ peritoneal 
macrophages from 10-12 week old male or female C57BL/6 mice. Data represent 5 mice per group 
pooled from two independent experiments. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. One-way 
ANOVA with Tukey’s multiple comparisons test. (B)  Frequency of cells expressing VSIG4 amongst 
F4/80hi macrophages obtained from the peritoneal cavity of unmanipulated C57BL/6 mice of indicated 
ages. Symbols represent individual animals and horizontal bars represent the mean. *P<0.05, 
****P<0.0001. Two-way ANOVA with Tukey’s multiple comparisons test. (C) Absolute number of 
B1 cells obtained from the peritoneal cavity of unmanipulated male and female mice at 6-8 weeks and 
14-16 weeks. Symbols represent individual animals and horizontal bars represent the mean. Data are 
pooled from four experiments with 9 (females, both time points), 8 (male, 6-8 weeks) or 13 (male, 14-
16 weeks) mice per group. Data for the 14-16 week time point taken from data in Figure 6G. 
****P<0.0001. Two-way ANOVA.  
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Fig. S8: Identification of leukocytes in peritoneal fluid during S. pneumoniae-induced peritonitis  
Gating strategy for the identification of leukocyte subsets in the peritoneal lavage fluid of mice that 
received PBS or 103 CFU S. pneumoniae.  
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